Advertisement

Search Results for "Intron A Renal Cell"

08:26 EDT 19th June 2013 | BioPortfolio

Original Source: Interferon Alpha-2b (Intron A) for Metastatic or Unresectable Clear Cell Renal Carcinoma

This study will determine the response rate of daily low dose interferon-alpha-2b in patients with metastatic or unresectable clear cell renal cell carcinoma.

Matching Channels

Matching News

Detailed views of RNA splicing

Scientists at Yale University have described in the greatest detail yet aspects of the chemical processes by which RNA carries out the expression of our genes. Visualizing group II intron catalysis th...

Renal Cell Tumors More Likely To Metastasize Better Identified By Chemical Shift MRI

Adding "chemical shift" techniques to MRI can help differentiate clear cell renal cell carcinoma from other types of renal cell cancer, a new study shows. That differentiation can help physicians bett...

Chemical shift MRI helps differentiate renal cell tumors more likely to metastasize

Adding "chemical shift" techniques to MRI can help differentiate clear cell renal cell carcinoma from other types of renal cell cancer, a new study shows. That differentiation can help physicians bett...

[Comment] Renal-cell carcinoma: a step closer to a new classification

Until the advent of next-generation sequencing, somatic genetic changes common in sporadic renal-cell carcinoma were largely unknown. Mutations in the VHL gene, discovered by linkage analysis in hered...

Possible alternative to biopsy discovered for renal cancer diagnosis

Combining positron emission tomography scanning with iodine-124 (124I)–girentuximab may offer an effective noninvasive method of diagnosing clear cell renal cell carcinoma in patients who present wi...

Study shows chemical shift MRI can help differentiate clear cell renal carcinoma from other renal cancer

Adding "chemical shift" techniques to MRI can help differentiate clear cell renal cell carcinoma from other types of renal cell cancer, a new study shows. That differentiation can help physicians bett...

Gene mutation findings classify renal cell carcinoma

Researchers have identified mutation-defined subtypes of clear cell renal cell carcinoma that have distinct clinical outcomes.

[Articles] Single nucleotide polymorphisms and risk of recurrence of renal-cell carcinoma: a cohort study

Patients with localised renal-cell carcinoma and the MET polymorphism rs11762213 might have an increased risk of recurrence after nephrectomy. If these results are further validated in a similar popul...

Matching PubMed Articles

An analysis of the human and mouse CXCR5 gene introns.

Both mouse and human chemokine receptor CXC motif 5 (CXCR5) genes exhibit one single intron interrupting the coding sequence. The mouse intron is 12053 nucleotides (nt) long; the human intron is 9603...

A group II intron encodes a functional LAGLIDADG homing endonuclease and self-splices under moderate temperature and ionic conditions.

A group II intron encoding a protein belonging to the LAGLIDADG family of homing endonucleases was identified in the mitochondrial rns gene of the filamentous fungus Leptographium truncatum, and the c...

Gene variants of XRCC4 and XRCC3 and their association with risk for urothelial bladder cancer.

The DNA double strand break repair gene XRCC4, an important caretaker of genome stability and XRCC3 are suggested to play an imperative role in the development of carcinogenesis. However, no evidence...

Endothelial Nitric Oxide Genotypes and Haplotypes Are Not Associated with End-Stage Renal Disease.

The identification of genetic markers associated with chronic kidney disease (CKD) may help to predict its development. Because reduced nitric oxide (NO) bioavailability and endothelial dysfunction ar...

Intron creation and DNA repair.

The genesis of the exon-intron patterns of eukaryotic genes persists as one of the most enigmatic questions in molecular genetics. In particular, the origin and mechanisms responsible for creation of...

Search Whole site using Google

Loading
Search BioPortfolio:
Advertisement
Advertisement
Advertisement Advertisement